rs78877829

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_033124.5(DRC2):​c.880C>T​(p.Arg294Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0513 in 1,613,972 control chromosomes in the GnomAD database, including 2,609 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R294H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.043 ( 209 hom., cov: 32)
Exomes 𝑓: 0.052 ( 2400 hom. )

Consequence

DRC2
NM_033124.5 missense

Scores

2
5
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.83

Publications

11 publications found
Variant links:
Genes affected
DRC2 (HGNC:29937): (coiled-coil domain containing 65) This gene encodes a sperm tail protein that is highly expressed in adult testis, spermatocytes and spermatids. The protein plays a critical role in the assembly of the nexin-dynein regulatory complex. Mutations in this gene result in primary ciliary dyskinesia. [provided by RefSeq, Nov 2013]
DRC2 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 27
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017585754).
BP6
Variant 12-48918757-C-T is Benign according to our data. Variant chr12-48918757-C-T is described in ClinVar as Benign. ClinVar VariationId is 262221.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0598 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DRC2NM_033124.5 linkc.880C>T p.Arg294Cys missense_variant Exon 6 of 8 ENST00000320516.5 NP_149115.2 Q8IXS2-1
DRC2NM_001286957.2 linkc.451C>T p.Arg151Cys missense_variant Exon 6 of 8 NP_001273886.1 B4DXQ7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC65ENST00000320516.5 linkc.880C>T p.Arg294Cys missense_variant Exon 6 of 8 1 NM_033124.5 ENSP00000312706.4 Q8IXS2-1
ENSG00000272822ENST00000398092.4 linkc.385-14849G>A intron_variant Intron 4 of 4 3 ENSP00000438507.1 F5H423

Frequencies

GnomAD3 genomes
AF:
0.0428
AC:
6513
AN:
152024
Hom.:
209
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0105
Gnomad AMI
AF:
0.0570
Gnomad AMR
AF:
0.0332
Gnomad ASJ
AF:
0.0190
Gnomad EAS
AF:
0.00115
Gnomad SAS
AF:
0.0106
Gnomad FIN
AF:
0.109
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0613
Gnomad OTH
AF:
0.0340
GnomAD2 exomes
AF:
0.0415
AC:
10442
AN:
251482
AF XY:
0.0419
show subpopulations
Gnomad AFR exome
AF:
0.00769
Gnomad AMR exome
AF:
0.0178
Gnomad ASJ exome
AF:
0.0188
Gnomad EAS exome
AF:
0.00147
Gnomad FIN exome
AF:
0.0995
Gnomad NFE exome
AF:
0.0590
Gnomad OTH exome
AF:
0.0414
GnomAD4 exome
AF:
0.0522
AC:
76358
AN:
1461830
Hom.:
2400
Cov.:
33
AF XY:
0.0511
AC XY:
37157
AN XY:
727222
show subpopulations
African (AFR)
AF:
0.00738
AC:
247
AN:
33480
American (AMR)
AF:
0.0196
AC:
875
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0197
AC:
514
AN:
26136
East Asian (EAS)
AF:
0.000605
AC:
24
AN:
39700
South Asian (SAS)
AF:
0.0121
AC:
1045
AN:
86258
European-Finnish (FIN)
AF:
0.0981
AC:
5238
AN:
53420
Middle Eastern (MID)
AF:
0.00590
AC:
34
AN:
5760
European-Non Finnish (NFE)
AF:
0.0591
AC:
65673
AN:
1111962
Other (OTH)
AF:
0.0448
AC:
2708
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
3829
7657
11486
15314
19143
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2292
4584
6876
9168
11460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0428
AC:
6511
AN:
152142
Hom.:
209
Cov.:
32
AF XY:
0.0446
AC XY:
3320
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.0105
AC:
435
AN:
41494
American (AMR)
AF:
0.0332
AC:
507
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0190
AC:
66
AN:
3468
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5190
South Asian (SAS)
AF:
0.0102
AC:
49
AN:
4812
European-Finnish (FIN)
AF:
0.109
AC:
1154
AN:
10588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0613
AC:
4171
AN:
67988
Other (OTH)
AF:
0.0336
AC:
71
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
308
617
925
1234
1542
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0506
Hom.:
846
Bravo
AF:
0.0346
TwinsUK
AF:
0.0591
AC:
219
ALSPAC
AF:
0.0607
AC:
234
ESP6500AA
AF:
0.0109
AC:
48
ESP6500EA
AF:
0.0555
AC:
477
ExAC
AF:
0.0413
AC:
5008
Asia WGS
AF:
0.00606
AC:
21
AN:
3478
EpiCase
AF:
0.0534
EpiControl
AF:
0.0520

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 24, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 27 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.27
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.11
.;.;T
Eigen
Uncertain
0.58
Eigen_PC
Uncertain
0.51
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.79
T;T;T
MetaRNN
Benign
0.0018
T;T;T
MetaSVM
Benign
-0.89
T
PhyloP100
2.8
PrimateAI
Benign
0.37
T
PROVEAN
Pathogenic
-5.4
D;D;D
REVEL
Benign
0.14
Sift
Uncertain
0.0010
D;D;D
Sift4G
Uncertain
0.0030
D;D;D
Polyphen
1.0
.;.;D
Vest4
0.26
MPC
0.37
ClinPred
0.026
T
GERP RS
4.7
Varity_R
0.21
gMVP
0.31
Mutation Taster
=89/11
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78877829; hg19: chr12-49312540; COSMIC: COSV56740449; COSMIC: COSV56740449; API